Low incidence of adverse experiences after measles or measles-rubella mass revaccination at a college campus.
A postvaccination questionnaire and review of student and employee clinic visits were carried out at Notre Dame University in the spring of 1990 after mass campus revaccination with measles or measles-rubella vaccines in the autumn of 1989, in order to assess the incidence of adverse experiences after revaccination. Rates of adverse experiences (AE), which included chiefly local injection site discomfort and flu-like symptoms, among respondents were 6.6% and 13.4%, male and female students, respectively, and 9.3% and 25%, male and female employees, respectively. Rates of joint-related complaints (4%) were lower than reported after primary vaccination, particularly in young adult women. AEs in general, and joint reaction rates in particular, were generally mild and transient, and only 0.23% resulted in a clinic visit. Revaccination of prior vaccinees appears to be associated with relatively low AE rates.
Seager
C
C
Department of University Health Services, University of Notre Dame, IN.
Moriarity
J
J
Ngai
A
A
Staehle
B O
BO
Nalin
D R
DR
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D007117:Immunization, Secondary / Q000009:adverse effects*; D015994:Incidence; D007196:Indiana / Q000453:epidemiology; D007279:Injections, Subcutaneous; D008297:Male; D008458:Measles Vaccine / Q000009:adverse effects*; D012411:Rubella Vaccine / Q000009:adverse effects*; D013333:Student Health Services; D011795:Surveys and Questionnaires
D008458:Measles Vaccine; D012411:Rubella Vaccine